Therapeutic Isotopes Supply and Production
Sustainable. Scalable. Efficient.

Learn more

Who we are

Colibri Isotopes Corporation is a medical isotopes research, development and supply company.

At the core of our expertise is target design and physicochemical separation solutions for reactor- and accelerator-based therapeutic isotopes production.

Colibri is focusing on production of Lu-177, Ac-225, Ra-223, Tb-161 and Pb-212.

Our team has developed a unique technology and system for Lu-177 nca production, which allow the customer to set up the most reliable, cost-effective and globally scalable supply chain for Lu-177.

Colibri is developing an accelerator-based production route for Ac-225 with the use of physicochemical separation technologies providing the purest final product on the market.

News

February2024
News
Colibri receives patent (U.S. Pat. No. 11,894,156)
November2023
News
Morpho tests the Kalupso module at Colibri’s facility